
|Videos|June 30, 2022
ApiJect’s Strategy and Adaptation of BFS Technology
Author(s)Apiject
BFS technology allows for rapid scale-up with flexible production runs, a versatile supply chain, and versatile product development.
Any formulation is checked for compatibility in ApiJect’s container, where they look for a loss of potency and impurities compared to other containers that are used.
To meet the demand in the market, ApiJect is working with external supply chains for contract manufacturing.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
3
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5




